Multipotent mesenchymal stem cells reduce interstitial fibrosis but do not delay progression of chronic kidney disease in collagen4A3-deficient mice
Authors:
- O. GrossOGO. Gross
- S. SegererSSS. Segerer
- R. HoffmannRHR. Hoffmann
- E. RadomskaERE. Radomska
- A. BuchstallerABA. Buchstaller
- R. HussRHR. Huss
- N. AkisNAN. Akis
- D. SchlöndorffDSD. Schlöndorff
- H.-J. AndersHAH.-J. Anders
- 1 July 2006
- journal article
- Published by Elsevier in Kidney International
- Vol. 70 (1) , 121-129
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Administered mesenchymal stem cells protect against ischemic acute renal failure through differentiation-independent mechanismsAmerican Journal of Physiology-Renal Physiology, 2005
- Clarification of the nomenclature for MSC: The International Society for Cellular Therapy position statementCytotherapy, 2005
- Improved Arteriogenesis with Simultaneous Skeletal Muscle Repair in Ischemic Tissue by SCL+ Multipotent Adult Progenitor Cell Clones from Peripheral BloodJournal of Vascular Research, 2004
- Progenitor cells in the kidney: Biology and therapeutic perspectivesKidney International, 2004
- Circulating fibrocytes traffic to the lungs in response to CXCL12 and mediate fibrosisJournal of Clinical Investigation, 2004
- Mesenchymal Stem Cells Are Renotropic, Helping to Repair the Kidney and Improve Function in Acute Renal FailureJournal of the American Society of Nephrology, 2004
- Adult Stem Cells for Tissue Repair — A New Therapeutic Concept?New England Journal of Medicine, 2003
- Evidence that fibroblasts derive from epithelium during tissue fibrosisJournal of Clinical Investigation, 2002
- Human Mesenchymal Stem Cells Differentiate to a Cardiomyocyte Phenotype in the Adult Murine HeartCirculation, 2002
- Multilineage Potential of Adult Human Mesenchymal Stem CellsScience, 1999